Patrick G. Enright - 23 Jun 2025 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director
Signature
/s/ Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Issuer symbol
VERA
Transactions as of
23 Jun 2025
Transactions value $
$5,277,311
Form type
4
Filing time
25 Jun 2025, 20:07:16
Previous filing
12 Jun 2025
Next filing
11 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ENRIGHT PATRICK G Director C/O LONGITUDE CAPITAL MANAGEMENT, 2740 SAND HILL ROAD, 2ND FLOOR, MENLO PARK /s/ Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright 25 Jun 2025 0001253886

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $1.46M +69.8K +4.07% $20.87 1.78M 23 Jun 2025 See footnote F1, F2
transaction VERA Class A Common Stock Purchase $2.91M +140K +4.07% $20.87 3.57M 23 Jun 2025 See footnote F1, F3
transaction VERA Class A Common Stock Purchase $303K +13.5K +0.76% $22.35 1.8M 24 Jun 2025 See footnote F2, F4
transaction VERA Class A Common Stock Purchase $605K +27.1K +0.76% $22.35 3.6M 24 Jun 2025 See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $20.43 to $21.05, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 1 to this Form 4.
F2 These shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F3 These shares are held by Longitude Venture Partners IV, L.P ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F4 The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $21.67 to $22.50, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 4 to this Form 4.